Search for: "Price v. City of Chicago" Results 81 - 100 of 232
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jul 2018, 10:40 am by Kevin Kaufman
Instead, companies are being pulled toward New York City, Boston, and Chicago. [read post]
19 Jun 2018, 4:00 am by Edith Roberts
” At Law.com, Marcia Coyle reports that “[t]he Justice Department is asking the Supreme Court to stay the injunction to the extent it applies beyond the city of Chicago. [read post]
23 Apr 2018, 8:28 am by Dan Carvajal
Some view property tax limitations as a sensible constraint on the growth of government, or as a fail-safe to avoid pricing people out of their own homes. [read post]
12 Dec 2017, 9:57 am by Wolfgang Demino
(Peter Thomas Lane, Schlanger & Schlanger LLP, Pleasantville, N.Y.; Owen Randolph Bragg, Horwitz, Horwitz & Associates, Chicago, IL, on the brief), for Saliha Madden.Thomas Arthur Leghorn (Joseph L. [read post]
12 Dec 2017, 9:57 am by Wolfgang Demino
(Peter Thomas Lane, Schlanger & Schlanger LLP, Pleasantville, N.Y.; Owen Randolph Bragg, Horwitz, Horwitz & Associates, Chicago, IL, on the brief), for Saliha Madden.Thomas Arthur Leghorn (Joseph L. [read post]
4 Aug 2017, 5:00 am by Kenneth J. Vanko
I ran a race (the Bix7 in the lovely Quad Cities), and - oh yea - I tried a case in Chicago. [read post]
16 Jun 2017, 12:50 pm by Dan Ernst
  After the jump are the panels sponsored by the  Law and History CRN a next week's annual meeting in Mexico City. [read post]
1 May 2017, 5:00 am by Mike Madison
Lower cost, lower priced, lower quality competition that substitutes for existing, expensive, quality stuff. [read post]
30 Apr 2017, 2:58 pm by Jeffrey May
Court of Appeals in New York City that vacated a district court judgment against Chinese vitamin C manufacturers for fixing prices on comity grounds, arguing that the decision could not be reconciled with rules followed by other circuits. [read post]
27 Apr 2017, 1:30 am by Thaddeus Mason Pope, JD, PhD
Kline School of Law, Taming Pharma with Benefit CorporationsDmitry Karshtedt, The George Washington University Law School, Regulating ‘Evergreening’: The FDA's Role in the Creation of Balanced Rights for Pharmaceutical ImprovementsMichael Sinha, Brigham and Women's Hospital and Harvard Medical School, Legal Approaches to Ensuring Timely Generic Drug AvailabilityRebecca Wolitz, Stanford Law School, Patents, Preemption, and Price-Gouging Teaching Session 1G – Room… [read post]